| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |